Founded Year

2016

Stage

Corporate Minority | Alive

Total Raised

$334.1M

Last Raised

$80M | 2 mos ago

About Owkin

Owkin specializes in AI technologies applied to clinical research with the aim of developing better drugs and treatments for patients. The company's purpose is to empower researchers in hospitals, universities and the biopharma industry to i) understand why drug efficacy varies from patient to patient, ii) improve the drug development process and iii) to help identify key drugs and treatments for each individual patient to improve patient outcomes. The company's precision medicine platform aims to enable medical insights for drug discovery and development by connecting life sciences firms with academic researchers and hospitals. The Owkin platform aims to enable partners to uncover siloed datasets while maintaining patient privacy and securing proprietary data using Federated Learning and innovative collaborative AI technology.

Owkin Headquarters Location

831 Broadway Unit 3R

New York, New York, 10003,

United States

ESPs containing Owkin

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Life Sciences / Biopharma Tech

Companies in this market offer alternative datasets that can supplement clinical trial data and improve the likelihood of trial success. These companies collect data from a variety of sources, such as patient registries, EHRs, insurance databases, social media, and patient research networks.

Owkin named as Challenger among 15 other companies, including Datavant, Syapse, and Evidation.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Owkin

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Owkin is included in 13 Expert Collections, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,182 items

C

Clinical Trials Tech

329 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

A

AI 100

400 items

A

Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

D

Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

B

Biopharma Tech

6,405 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Owkin Patents

Owkin has filed 4 patents.

The 3 most popular patent topics include:

  • Artificial neural networks
  • Classification algorithms
  • Machine learning
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/23/2021

Machine learning, Artificial neural networks, Image processing, Classification algorithms, Computer vision

Application

Application Date

2/23/2021

Grant Date

Title

Related Topics

Machine learning, Artificial neural networks, Image processing, Classification algorithms, Computer vision

Status

Application

Latest Owkin News

10 AI healthcare startups with the most funding

Aug 15, 2022

Noah Schwartz - Monday, August 15th, 2022 Big Data analytics company and magazine Analytics Insight created a list of the 10 artificial intelligence startup companies with the most funding in 2022. Here are the findings from the Aug. 13 report: Note: Companies are listed in alphabetical order. Argo — Argo is an AI-driving company that has received $3.6 billion in corporate bonds. Castor — Castor is a New York City-based artificial intelligence company that received $23.5 million in series A funding. CloudMinds — This robotics software company based out of Irvine, Calif., raised $486.6 million in series B funding. DataRobot — Boston-based company DataRobot uses AI to help businesses cut costs. The company raised $700 million over all investment rounds. Delphia — A Toronto-based startup. Delphia uses AI to help analyze datasets. Delphia received $60 million in series A.  H2O.Ai — H2O.Ai is a Mountain View, Calif.-based AI company that creates analytics models. The company raised $251.1 million in series E. Observe.AI — Observe.AI uses AI for data analysis. The San Francisco-based company received $214 million in series C funding. Osaro — Osaro is a San Francisco-based company using AI to help robots move. Osaro received $96.3 million in series C funding. Owkin — Owkin is a medical AI company based in New York City. The company raised $80 million in funding. Papercup — Papercup is a company based out of London attempting to bring human emotions to AI dubbing services. The company raised $20 million in series A.

Owkin Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Owkin Rank

  • When was Owkin founded?

    Owkin was founded in 2016.

  • Where is Owkin's headquarters?

    Owkin's headquarters is located at 831 Broadway, New York.

  • What is Owkin's latest funding round?

    Owkin's latest funding round is Corporate Minority.

  • How much did Owkin raise?

    Owkin raised a total of $334.1M.

  • Who are the investors of Owkin?

    Investors of Owkin include Bristol-Myers Squibb, Sanofi Ventures, Plug and Play Accelerator, Bpifrance, Mubadala Capital and 10 more.

  • Who are Owkin's competitors?

    Competitors of Owkin include Syapse, Lunit, Bio-AI Health, Imagene, Unlearn, Savana, Mendel.ai, ConcertAI, Huma, Decentriq and 37 more.

You May Also Like

Tempus Logo
Tempus

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions.

ConcertAI Logo
ConcertAI

ConcertAI specializes in integrated clinical RWD, AI solutions and outcomes science with a large RWD oncology dataset. ConcertAI develops a medical research tool suite that offers care-based oncology research and data analytics.

Evidation Logo
Evidation

Evidation measures health in everyday life and enables anyone to participate in research and health programs. Evidation is a two-sided platform that connects individuals and enterprises. On the consumer side, the company assists individuals to participate in research including testing of digital health programs. On the enterprise side, Evidation provides biopharma, med-tech, big tech, academic institutions, professional societies, and government partners the ability to: generate evidence; and design, test, and deploy programs that motivate evidence-based action.

M
Mango Sciences

Mango Sciences is an emerging market data science company that connects underrepresented patients to precision medicine. The company's platform utilizes AI analytics to transform deep clinical data into key insights. It is based in Boston, Massachusetts.

Datavant Logo
Datavant

Datavant is dedicated to accelerating the discovery, development, and commercialization of new medicines through machine learning. It aims to partner with biomedical research institutions to eliminate silos of information and unlock insights from healthcare data.

T
TriNetX

TriNetX is the global health research network that optimizes clinical research and enables discoveries through the creation of real-world evidence. TriNetX combines real-time access to longitudinal clinical data with analytics to answer complex research questions.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.